Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-046285
Filing Date
2024-11-07
Accepted
2024-11-07 16:16:03
Documents
72
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20240930.htm   iXBRL 10-Q 1405311
2 EX-31.1 lyel-20240930x10qxexx311.htm EX-31.1 10651
3 EX-31.2 lyel-20240930x10qxexx312.htm EX-31.2 10621
4 EX-32.1 lyel-20240930x10qxexx321.htm EX-32.1 7503
10 lyel-20240930_g1.jpg GRAPHIC 191889
11 lyel-20240930_g2.jpg GRAPHIC 38080
12 lyel-20240930_g3.jpg GRAPHIC 127948
13 lyel-20240930_g4.jpg GRAPHIC 59756
14 lyel-20240930_g5.jpg GRAPHIC 57792
15 lyel-20240930_g6.jpg GRAPHIC 12791
  Complete submission text file 0001628280-24-046285.txt   7960593

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20240930.xsd EX-101.SCH 43846
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20240930_cal.xml EX-101.CAL 52855
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20240930_def.xml EX-101.DEF 231201
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20240930_lab.xml EX-101.LAB 625877
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20240930_pre.xml EX-101.PRE 435517
75 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20240930_htm.xml XML 811628
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 241435996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)